Dynamic matrisome: ECM remodeling factors licensing cancer progression and metastasis
The main cause of cancer-related mortality, metastasis, is a complex, multi-step process.
The extracellular matrix (ECM) component of solid tumors has been implicated in metastatic …
The extracellular matrix (ECM) component of solid tumors has been implicated in metastatic …
[HTML][HTML] Present and future possibilities for early diagnosis of hepatocellular carcinoma
P Stefaniuk, J Cianciara… - World journal of …, 2010 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) represents the fifth most common cancer in the world, and
the third most frequent oncological cause of death. The incidence of HCC is on the increase …
the third most frequent oncological cause of death. The incidence of HCC is on the increase …
Immunotherapy against several tumors, such as lung cancer, including NSCLC
T Weinschenk, S Walter, J Fritsche, S Colette… - US Patent …, 2018 - Google Patents
A method of treating a patient who has non-small cell lung carcinoma (NSCLC), lung cancer,
gastric cancer, and/or glioblastoma includes administering to said patient a composition …
gastric cancer, and/or glioblastoma includes administering to said patient a composition …
Novel immunotherapy against several tumors, such as lung cancer, including nsclc
T Weinschenk, S Walter, J Fritsche, S Colette, H Singh - 2015 - Google Patents
The present invention relates to peptides, nucleic acids and cells for use in
immunotherapeutic methods. In particular, the present invention relates to the …
immunotherapeutic methods. In particular, the present invention relates to the …
[HTML][HTML] Serum biomarkers and ultrasensitive biosensors for diagnosis of early-stage hepatocellular carcinoma
LDS Lapitan Jr, M Pietrzak, M Krawczyk… - Sensors and Actuators B …, 2023 - Elsevier
Hepatocellular carcinoma (HCC) was the third leading cause of cancer-related death
globally in 2020. The treatment of the disease is complex, with a high possibility of disease …
globally in 2020. The treatment of the disease is complex, with a high possibility of disease …
Hepatocellualar carcinoma serum markers
G Bertino, A Ardiri, M Malaguarnera… - Seminars in …, 2012 - Elsevier
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in some
areas of the world. In most cases, HCC is diagnosed at a late stage. Therefore, the …
areas of the world. In most cases, HCC is diagnosed at a late stage. Therefore, the …
IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease
F Calabrese, S Baraldo, E Bazzan… - American journal of …, 2008 - atsjournals.org
Rationale: Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory
disorder of the lung, yet the mechanisms that regulate this immune-inflammatory response …
disorder of the lung, yet the mechanisms that regulate this immune-inflammatory response …
[HTML][HTML] Squamous cell carcinoma antigen: clinical application and research status
H Zhu - Diagnostics, 2022 - mdpi.com
The squamous cell carcinoma antigen (SCCA) is a tumor marker that has gained increasing
attention for its biological functions and significance in normal physiological and …
attention for its biological functions and significance in normal physiological and …
[HTML][HTML] Biomarkers in hepatocellular carcinoma: current status and future perspectives
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and one of the
leading causes of cancer-related death worldwide. HCC is highly heterogeneous, both …
leading causes of cancer-related death worldwide. HCC is highly heterogeneous, both …
SERPINB3 and B4: From biochemistry to biology
Human SERPINB3 and SERPINB4 are evolutionary duplicated serine/cysteine protease
inhibitors. Genomic analysis indicates that these paralogous genes were encoded from …
inhibitors. Genomic analysis indicates that these paralogous genes were encoded from …